Select a Sector or Industry
Drug Delivery & Accessories Stock Rankings
-
Accounts Payable
-
Accounts Receivable
-
Accruals
Pro
-
Altman Z-Score
Pro
-
Asset Utilization
-
Beneish M-Score
Pro
-
Book Value
-
Book Value per Share
-
Capital Expenditures
-
Cash Conversion Cycle
Pro
-
Cash Div. Payout Ratio TTM
Pro
-
Cash Financing
-
Cash Financing TTM
-
Cash Investing
-
Cash Investing TTM
-
Cash Operations
-
Cash Operations TTM
-
Cash and Equivalents
-
Cash and ST Investments
-
Current Ratio
-
Days Inventory Outstanding
Pro
-
Days Payable Outstanding
Pro
-
Days Sales Outstanding
Pro
-
Debt to Equity Ratio
-
Dividend Yield
-
EBITDA Margin TTM
Pro
-
EBITDA TTM
Pro
-
EV / EBIT
Pro
-
EV / EBITDA
Pro
-
EV / Free Cash Flow
Pro
-
EV / Revenues
Pro
-
Earnings Per Share
-
Earnings Per Share Growth
-
Earnings Per Share TTM
-
Earnings Yield
-
Effective Tax Rate TTM
Pro
-
Enterprise Value
-
Expenses
-
Expenses TTM
-
Free Cash Flow
-
Free Cash Flow TTM
-
Free Cash Flow Yield
Pro
-
Fundamental Score
Pro
-
Gross Profit Margin
-
Gross Profit TTM
-
Income from Cont. Ops
Pro
-
Interest Expense
-
Interest Income
-
Inventories
-
KZ Index
Pro
-
Liabilities
-
Long Term Debt
-
Market Cap
-
Net Income
-
Net Income TTM
-
Net PP&E
-
Operating Earnings Yield
Pro
-
Operating Margin TTM
Pro
-
Operating PE Ratio
Pro
-
Other Comprehensive Income
Pro
-
PE 10
Pro
-
PE Ratio
-
PE Value
Pro
-
PEG Ratio
-
PS Value
Pro
-
Payout Ratio TTM
Pro
-
Price
-
Price / Book Value
-
Price / Sales Ratio
-
Price / Tangible Book Value
Pro
-
Profit Margin
-
R&D Expense
-
Receivables Turnover
-
Retained Earnings
-
Retained Earnings Growth
-
Return on Assets
-
Return on Equity
-
Return on Invested Capital
Pro
-
Revenue Growth
-
Revenue Per Share TTM
-
Revenues
-
Revenues TTM
-
SG&A Expense
-
Shareholders Equity
-
Shares Outstanding
-
Stock Buybacks
-
Tangible Book Value
Pro
-
Tangible Book Value Per Share
Pro
-
Tangible Common Equity Ratio
Pro
-
Times Interest Earned TTM
Pro
-
Total Assets
-
Valuation (Historical Mult.)
Pro
-
Valuation Percentage
Pro
-
Value Score
Pro
Select from over 70 financial rankings
Or choose from these popular rankings:
Market Cap
View All
1
VRX
Valeant Pharmaceuticals Internat...
14.41B
2
ELN
Elan Corporation
7.891B
3
HSP
Hospira
5.174B
4
ALKS
Alkermes
1.959B
5
PETS
PetMed Express
227.20M
PE Ratio
View All
1
CBRX
Columbia Laboratories
3.238
2
ACUR
Acura Pharmaceuticals
11.61
3
PETS
PetMed Express
13.96
4
ELN
Elan Corporation
17.39
5
VRX
Valeant Pharmaceuticals Internat...
109.30
Dividend Yield
View All
1
PETS
PetMed Express
5.30%
2
VRX
Valeant Pharmaceuticals Internat...
0.00%
2
KV.A
KV Pharmaceutical
0.00%
2
CBRX
Columbia Laboratories
0.00%
2
PSDV
pSivida
0.00%
Return on Equity
View All
1
CBRX
Columbia Laboratories
161.5%
2
ELN
Elan Corporation
75.00%
3
ACUR
Acura Pharmaceuticals
32.06%
4
PETS
PetMed Express
19.69%
5
VRX
Valeant Pharmaceuticals Internat...
3.26%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Market Cap
View All| 1 | VRX | Valeant Pharmaceuticals Internat... | 14.41B |
|---|---|---|---|
| 2 | ELN | Elan Corporation | 7.891B |
| 3 | HSP | Hospira | 5.174B |
| 4 | ALKS | Alkermes | 1.959B |
| 5 | PETS | PetMed Express | 227.20M |
PE Ratio
View All| 1 | CBRX | Columbia Laboratories | 3.238 |
|---|---|---|---|
| 2 | ACUR | Acura Pharmaceuticals | 11.61 |
| 3 | PETS | PetMed Express | 13.96 |
| 4 | ELN | Elan Corporation | 17.39 |
| 5 | VRX | Valeant Pharmaceuticals Internat... | 109.30 |
Dividend Yield
View All| 1 | PETS | PetMed Express | 5.30% |
|---|---|---|---|
| 2 | VRX | Valeant Pharmaceuticals Internat... | 0.00% |
| 2 | KV.A | KV Pharmaceutical | 0.00% |
| 2 | CBRX | Columbia Laboratories | 0.00% |
| 2 | PSDV | pSivida | 0.00% |
Return on Equity
View All| 1 | CBRX | Columbia Laboratories | 161.5% |
|---|---|---|---|
| 2 | ELN | Elan Corporation | 75.00% |
| 3 | ACUR | Acura Pharmaceuticals | 32.06% |
| 4 | PETS | PetMed Express | 19.69% |
| 5 | VRX | Valeant Pharmaceuticals Internat... | 3.26% |